Stay updated on Setmelanotide in BBS and AS for Obesity Clinical Trial
Sign up to get notified when there's something new on the Setmelanotide in BBS and AS for Obesity Clinical Trial page.

Latest updates to the Setmelanotide in BBS and AS for Obesity Clinical Trial page
- CheckyesterdayChange DetectedA minor update to the ClinicalTrials.gov page release/version label (v3.5.2 → v3.5.3) with no change to the displayed study details.SummaryDifference0.3%

- Check8 days agoChange DetectedThe page now shows Revision: v3.5.2, replacing the previous Revision: v3.5.0.SummaryDifference0.2%

- Check16 days agoChange DetectedUpdated the study record with results-related information and revised dates. Included details such as the results posting date and study completion.SummaryDifference0.2%

- Check23 days agoChange DetectedAlström syndrome was added to the list of study conditions, explicitly including AS in the study details.SummaryDifference0.2%

- Check30 days agoChange DetectedNo substantive changes detected; the page content appears unchanged across the two screenshots.SummaryDifference0.2%

- Check37 days agoChange DetectedAdded a new publication citation for the Phase 3 BBS trial (Argente et al.). Updated the page revision to v3.5.0 and removed the prior 'Online ahead of print' citation (v3.4.3).SummaryDifference0.2%

Stay in the know with updates to Setmelanotide in BBS and AS for Obesity Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Setmelanotide in BBS and AS for Obesity Clinical Trial page.